{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:20:53Z","timestamp":1775600453292,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.atherosclerosis.2017.10.020","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T13:12:51Z","timestamp":1508764371000},"page":"110-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide"],"prefix":"10.1016","volume":"267","author":[{"given":"Rea","family":"Valaperta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"De Siena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Cardani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunata","family":"Lombardia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8102-3324","authenticated-orcid":false,"given":"Edina","family":"Cenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Rampoldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Brigonzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Rigolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Gaia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Meola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6819-6818","authenticated-orcid":false,"given":"Raffaele","family":"Bugiardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib1","series-title":"Myotonic Dystrophy","author":"Harper","year":"2001"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbadis.2014.05.019","article-title":"Myotonic dystrophies: an update on clinical aspects, genetic, pathology, and molecular pathomechanisms","volume":"1852","author":"Meola","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib3","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/jama.2012.346","article-title":"Electrophysiological study with prophylactic pacing and survival in adults with myotonic dystrophy and conduction system disease","volume":"307","author":"Wahbi","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1540-8159.2010.02905.x","article-title":"Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy","volume":"34","author":"Nazarian","year":"2011","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.08.037","article-title":"Cardiac manifestations of myotonic dystrophy type 1","volume":"160","author":"Petri","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib6","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1212\/01.WNL.0000147335.10783.E4","article-title":"Sudden cardiac death in myotonic dystrophy type 2","volume":"63","author":"Schoser","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.nmd.2009.04.012","article-title":"Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control study","volume":"19","author":"Wahbi","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib8","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0960-8966(02)00213-4","article-title":"107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, The Netherlands","volume":"13","author":"Bushby","year":"2003","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/hrt.63.2.119","article-title":"Cardiac involvement in congenital myotonic dystrophy","volume":"63","author":"Forsberg","year":"1990","journal-title":"Br. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/adc.68.2.177","article-title":"The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects","volume":"68","author":"Reardon","year":"1993","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ijcard.2006.06.056","article-title":"Early detection of biventricular involvement in myotonic dystrophy by tissue Doppler","volume":"118","author":"Parisi","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jacc.2011.08.026","article-title":"Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T","volume":"58","author":"Jaffe","year":"2011","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib13","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2014.03.027","article-title":"Elevation of cardiac troponin T, but not cardiac troponin I, in patients with neuromuscular diseases: implications for the diagnosis of myocardial infarction","volume":"63","author":"Rittoo","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib14","doi-asserted-by":"crossref","first-page":"958510","DOI":"10.1155\/2013\/958510","article-title":"Identification and characterization of DM1 patients by a new diagnostic certified assay: neuromuscular and cardiac assessments","volume":"2013","author":"Valaperta","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/gtmb.2015.0135","article-title":"Development and validation of a new molecular diagnostic assay for detection of myotonic dystrophy type 2","volume":"19","author":"Valaperta","year":"2015","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib16","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1056\/NEJMoa062800","article-title":"Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1","volume":"358","author":"Groh","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib17","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"Lang","year":"2005","journal-title":"J.\u00a0Am. Soc. Echocardiogr."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib18","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1373\/clinchem.2009.132654","article-title":"Analytical validation of a high-sensitivity cardiac troponin T assay","volume":"56","author":"Giannitsis","year":"2010","journal-title":"Clin. Chem."},{"issue":"58 (Suppl)","key":"10.1016\/j.atherosclerosis.2017.10.020_bib19","article-title":"Development of a highly sensitive immunoassay for cardiac troponin I for the ARCHITECT i2000SR and i1000SR analyzers","author":"Lipowsky","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1373\/clinchem.2011.165795","article-title":"IFCC task force on clinical applications of cardiac biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays","volume":"58","author":"Apple","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S1388-9842(03)00108-9","article-title":"Reference ranges for natriuretic peptides for diagnostic use are dependent on age, gender and heart rate","volume":"5","author":"Loke","year":"2003","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/heart.89.7.745","article-title":"The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population","volume":"89","author":"Raymond","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib23","first-page":"167","article-title":"N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease","volume":"51","author":"Hess","year":"2005","journal-title":"Clin. Lab."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cccn.2005.04.031","article-title":"Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donors","volume":"360","author":"Hess","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.amjcard.2011.06.057","article-title":"Reference limits for N-terminal-pro-B-type natriuretic peptide in healthy individuals (from the Framingham Heart Study)","volume":"108","author":"Fradley","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib26","unstructured":"Elecsys proBNP package inserts. http:\/\/www.rochecanada.com\/content\/dam\/roche_canada\/en_CA\/documents\/package_inserts\/Elecsys%20proBNP%20II_04842464190_CAN_V10_EN-final.pdf (accessed 15. 09. 2017)."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib27","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ejheart.2008.07.014","article-title":"State of the art: using natriuretic peptide levels in clinical practice","volume":"10","author":"Maisel","year":"2008","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib29","unstructured":"Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf2\/k022516.pdf (accessed 04.12.2016)."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib30","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.cardfail.2005.04.022","article-title":"Diagnostic and prognostic performance of N-terminal ProBNP in primary care patients with suspected heart failure","volume":"11","author":"Gustafsson","year":"2005","journal-title":"J.\u00a0Card. Fail."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib31","doi-asserted-by":"crossref","first-page":"H2596","DOI":"10.1152\/ajpheart.00215.2008","article-title":"Angiotensin II receptor antagonism reverts the selective cardiac BNP upregulation and secretion observed in myocarditis","volume":"294","author":"Ogawa","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1532-429X-14-48","article-title":"Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study","volume":"14","author":"Hermans","year":"2012","journal-title":"J.\u00a0Cardiovasc Magn. Reson"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0140-6736(93)92061-W","article-title":"Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy","volume":"342","author":"Raynolds","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ng.2007.28","article-title":"RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression","volume":"40","author":"Yadava","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nrcardio.2012.122","article-title":"Third universal definition of myocardial infarction","volume":"9","author":"Thygesen","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.cca.2016.10.026","article-title":"High-sensitive cardiac troponin T (hs-cTnT) assay as serum biomarker to predict cardiac risk in myotonic dystrophy: a case-control study","volume":"463","author":"Valaperta","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib37","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1016\/S0735-1097(02)01877-6","article-title":"Prognostic significance of elevated troponin I after percutaneous coronary intervention","volume":"39","author":"Cantor","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2017.10.020_bib38","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American heart association task force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017313400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T11:54:21Z","timestamp":1535284461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017313400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":38,"alternative-id":["S0021915017313400"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.020","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac involvement in myotonic dystrophy: The role of troponins and N-terminal pro B-type natriuretic peptide","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}